康達新材(002669.SZ)擬再次參與競拍上玻院
格隆匯12月3日丨康達新材(002669.SZ)公佈,根據阿里司法拍賣網絡平台2020年11月18日發佈的《上海華信國際集團有限公司等十五家關聯公司合併破產清算管理人關於拍賣上海玻璃鋼研究院有限公司100%股權和應收上海玻璃鋼研究院有限公司108,538,081.36元債權的公告》顯示,因第三次拍賣(2020年11月9日10時開拍)的競買人未按期足額支付拍賣餘款,視為悔拍。
管理人向上海市第三中級人民法院申請,於2020年12月3日12時-12月4日12時(延時除外)在阿里司法拍賣網絡平台對上述資產進行第四次公開拍賣,起拍價約為5.52億元。公司擬以自有或自籌資金參與該競拍事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.